Holen Sie sich die Stockscreener-App
3.225
0.77%
-0.025
Schlusskurs vom Vortag:
$3.25
Offen:
$3.27
24-Stunden-Volumen:
23,869
Relative Volume:
0.19
Marktkapitalisierung:
$165.65M
Einnahmen:
$63.69M
Nettoeinkommen (Verlust:
$-44.82M
KGV:
-1.6125
EPS:
-2
Netto-Cashflow:
$-30.56M
1W Leistung:
-1.38%
1M Leistung:
-5.15%
6M Leistung:
-12.60%
1J Leistung:
+115.00%
1-Tages-Spanne:
$3.21
$3.315
1-Wochen-Bereich:
$3.202
$3.425
52-Wochen-Spanne:
$1.36
$5.33
Mdxhealth Sa Stock (MDXH) Company Profile
Firmenname
Mdxhealth Sa
Sektor
Branche
Telefon
-
Adresse
-
Compare MDXH vs TMO, DHR, IDXX, A, WAT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MDXH
Mdxhealth Sa
|
3.225 | 166.93M | 63.69M | -44.82M | -30.56M | -2.00 |
|
TMO
Thermo Fisher Scientific Inc
|
469.64 | 176.79B | 44.56B | 6.72B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
186.47 | 131.71B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
570.68 | 45.48B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
111.67 | 31.55B | 7.07B | 1.29B | 993.00M | 4.5355 |
|
WAT
Waters Corp
|
285.13 | 27.79B | 3.17B | 642.63M | 516.49M | 10.77 |
Mdxhealth Sa Stock (MDXH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-17 | Eingeleitet | Craig Hallum | Buy |
| 2024-10-31 | Eingeleitet | Lake Street | Buy |
| 2023-05-31 | Eingeleitet | TD Cowen | Outperform |
| 2022-07-18 | Fortgesetzt | Oppenheimer | Outperform |
Mdxhealth Sa Aktie (MDXH) Neueste Nachrichten
MDxHealth SA Stock (ISIN: US55278X1072) Gains Momentum on Prostate Cancer Test Momentum - AD HOC NEWS
Mdxhealth Earnings Call Highlights Fast Growth, Rising Costs - TipRanks
How is MDxHealth SA managing supply chain issuesJuly 2025 Recap & Low Drawdown Investment Strategies - baoquankhu1.vn
BTIG reiterates MDxHealth stock rating on strong volume growth By Investing.com - Investing.com Canada
BTIG reiterates MDxHealth stock rating on strong volume growth - Investing.com
MDxHealth SA (MDXH.BR) Competitors - Meyka
Moving Averages: Whats the RSI of MDxHealth SA stockJuly 2025 Big Picture & Real-Time Market Sentiment Reports - baoquankhu1.vn
MDxHealth SA (NASDAQ:MDXH) Short Interest Down 23.1% in February - MarketBeat
Returns Recap: What are MDxHealth SAs earnings expectationsWeekly Risk Report & Verified Short-Term Trading Plans - baoquankhu1.vn
MDXH Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
MDxHealth S.A. Q4 2025 Earnings Call Summary - Yahoo Finance
Mdxhealth Q4 2025 revenue up 19% to USD 29.5M - Medical Buyer
MDxHealth ADR earnings missed by $0.04, revenue fell short of estimates - Investing.com Australia
MDXH Should I Buy - Intellectia AI
MDxHealth SA (MDXH) Q4 2025 Earnings Call Highlights: Strong Rev - GuruFocus
MDxHealth (NASDAQ:MDXH) Announces Earnings Results - MarketBeat
MDxHealth SA (MDXH) Q4 2025 Earnings Call Transcript Summary - 富途牛牛
MDxHealth (MDXH) Q4 2025 Earnings Call Transcript - The Globe and Mail
MDxHealth Q4 Earnings Call Highlights - MarketBeat
Earnings call transcript: MDxHealth misses Q4 2025 expectations, stock steady - Investing.com
MDXH Exceeds Revenue Expectations with Strong Q4 Performance - GuruFocus
MDxHealth SA reports results for the quarter ended December 31Earnings Summary - TradingView
MDxHealth Delivers 20% 2025 Revenue Growth and Names Interim CFO Ron Kalfus - TipRanks
Mdxhealth Announces Fourth Quarter and Full-Year 2025 Financial Results | Associated Press | syndication news - Enidnews.com
Cancer-test maker Mdxhealth narrows 2025 loss, guides 27-30% growth for 2026 - Stock Titan
Mdxhealth Announces Fourth Quarter and Full-Year 2025 Financial Results - Bitget
Dow Update: Should I invest in MDxHealth SA before earningsTrade Entry Report & Free Fast Entry Momentum Trade Alerts - baoquankhu1.vn
MDxHealth SA (NASDAQ:MDXH) Given Average Rating of “Moderate Buy” by Analysts - Defense World
MDxHealth SA (NASDAQ:MDXH) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Will MDxHealth SA stock benefit from infrastructure spendingPortfolio Update Report & Free Growth Oriented Trading Recommendations - mfd.ru
MDxHealth (MDXH) Projected to Post Quarterly Earnings on Thursday - Defense World
[EFFECT] MDxHealth SA SEC Filing - Stock Titan
Medtronic Just Posted Its Best Quarter in 2.5 Years - AOL.com
Aug Outlook: Should I invest in MDxHealth SA before earningsQuarterly Trade Report & Expert Curated Trade Ideas - baoquankhu1.vn
Mdxhealth to Present Fourth Quarter and Full Year 2025 Financial Results and Corporate Update on February 26 - The Manila Times
MDxHealth to Release Q4 and Full Year 2025 Financial Results on February 26, 2026, Followed by Conference Call - Quiver Quantitative
Mdxhealth to Present Fourth Quarter and Full Year 2025 Financial Results and Corporate Update on February 26 - GlobeNewswire Inc.
Bond Watch: Whats the RSI of MDxHealth SA stock2025 Top Gainers & Expert-Curated Trade Recommendations - baoquankhu1.vn
Can MDxHealth SA stock continue upward trendWeekly Loss Report & Stock Portfolio Risk Management - mfd.ru
MDxHealth Details Exosome Diagnostics Deal and Restructured GPS Earnout Obligations - TipRanks
Trading Action: Should I invest in MDxHealth SA before earningsJuly 2025 Earnings & Daily Volume Surge Signals - baoquankhu1.vn
Aug Shorts: Can Xcel Energy Inc disrupt its industryTrend Reversal & Real-Time Stock Entry Alerts - baoquankhu1.vn
Trend Recap: Whats the RSI of MDxHealth SA stockGlobal Markets & Verified Momentum Stock Watchlist - baoquankhu1.vn
MDxHealth SA (NASDAQ:MDXH) Short Interest Update - MarketBeat
MDxHealth SA (NASDAQ:MDXH) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Midday Stock Roundup: MDxHealth Up 9% Since Preliminary Q4, FY Results - Orange County Business Journal
Analysts Expect Breakeven For MDxHealth SA (NASDAQ:MDXH) Before Long - Sahm
MDxHealth SA (NASDAQ:MDXH) Sees Significant Increase in Short Interest - MarketBeat
Retail Surge: How interest rate cuts could boost MDxHealth SA stockSwing Trade & Community Trade Idea Sharing Platform - Bộ Nội Vụ
MDxHealth Posts Preliminary 2025 Results, Expects Revenue Growth Of 26% To 28% In 2026 - Nasdaq
MDxHealth reports 23% revenue growth in Q4, issues 2026 guidance By Investing.com - Investing.com India
Finanzdaten der Mdxhealth Sa-Aktie (MDXH)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.77%
0.17%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):